Tag: Stephen Van Deventer
April 9, 2020
Asterion Appoints Amy Stephenson as Chief Investment Officer
Asterion Cannabis announces the appointment of Amy Stephenson, MBA, CFA, CPA, CMA, as Chief Investment Officer. March 31, 2020
Asterion Signs DAA for $400 Million
Asterion Signs Exclusive Definitive Association Agreement for $400 Million Financing, Development and Construction March 9, 2020
Asterion Cannabis to Participate in the 32nd Annual ROTH Conference
Asterion Cannabis Inc. is pleased to announce that it will participate in the 32nd Annual ROTH Conference taking place in Orange County,... February 4, 2020
Asterion Cannabis Officially Listed on the Australian Department of Health and Office of Drug Control
Asterion Cannabis is listed as a medicinal cannabis manufacturer and supplier on the Australian government's Department of Health and Office of... January 27, 2020
Asterion Cannabis Announces Election of New Director
Asterion is pleased to announce the voting results from the Company's 2020 annual general meeting of shareholders held on Friday,...
November 13, 2018
PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H), (the "Company" or "PreveCeutical") announces that it has entered into a non-binding letter of intent dated November 9,... October 31, 2018